For research use only. Not for therapeutic Use.
Blinatumomab (Anatumomab) is a bispecific monoclonal antibody which can specifically targets the CD19 antigen present on B cells. Blinatumomab can be used for the research of acute lymphoblastic leukemia[1].
| Catalog Number | I043753 |
| CAS Number | 853426-35-4 |
| Purity | ≥95% |
| Reference | [1]. Kantarjian H, et, al. Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia. N Engl J Med. 2017 Mar 2;376(9):836-847. |
